GSK plc vs Johnson & Johnson — Stock Comparison

GSK
GSK plc
$51.61
▼ 1.34%
vs
JNJ
Johnson & Johnson
$227.19
▼ 1.16%
Q·Score Winner
Johnson & Johnson
JNJ7.1/10vs 6.3/10

Q·Score Breakdown

6.3
Neutral
Overall
7.1
Bullish
8.5
Quality
9.3
5.8
Health
6.5
5.8
Growth
5.1
6.7
Valuation
7.3
3.1
Sentiment
6.5
GSK

High-quality business with 41% return on equity and 18% profit margins.

cautious analyst consensus — few Buy ratings.

JNJ

High-quality business with 26% return on equity and 22% profit margins.

earnings contracting 53% year-over-year.

Analyst Consensus

HOLD
Target $57.65 (+11.7%)
8 analysts
BUY
Target $252.42 (+11.1%)
24 analysts

Fundamentals

GSK
JNJ
13.4×
Trailing P/E
26.3×
9.9×
Forward P/E
17.9×
17.8%
Profit Margin
21.8%
72.9%
Gross Margin
68.0%
40.9%
ROE
26.4%
1.5%
Revenue Growth
9.9%
8.4%
Earnings Growth
-52.9%
0.35
Beta
0.33
Price / Book
$103.0B
Market Cap
$546.9B
$35 – $62
52-Week Range
$146 – $252

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →